Skip to main content
Year archive

Novartis India Limited. — 2026 filings

All 35 regulatory filings released by Novartis India Limited. (NOVARTIND) in 2026, sourced directly from the official regulator.

35 Filings
2026 Period
2026 filings (35)
Filing Released Lang
Annual Secretarial Compliance Report for the financial year ended March 31, 2026.
Regulatory Filings
2026-05-22 English
Declaration of Voting Results of the Postal Ballot of Novartis India Limited ("The Company") and Scrutinizer''s Report.
Declaration of Voting Results & Voting Rights Announcements
2026-05-19 English
Declaration of Voting Results of the Postal ballot of Novartis India Limited ("The Company") and Scrutinizer''s report.
Declaration of Voting Results & Voting Rights Announcements
2026-05-19 English
Newspaper publication of the corrigendum to the Notice of Postal Ballot for the appointment of Ms. Gowree Gokhale as an Independent Director dated April 16, 2026
Regulatory Filings
2026-05-16 English
Corrigendum to the Notice of Postal Ballot issued on April 16, 2026, for the appointment of Ms. Gowree Gokhale (DIN: 09351661) as an Independent Director.
Proxy Solicitation & Information Statement
2026-05-15 English
Intimation of Newspaper advertisement by Novartis India Limited (''The Company'') regarding the publication of Audited Financial Results of the company for the quarter and financial year ....
Report Publication Announcement
2026-05-13 English
Integrated Financial Results for the Quarter and Financial Year ended March 31, 2026.
Interim / Quarterly Report FY 2026
2026-05-12 English
Outcome of the Board Meeting held on Tuesday, May 12, 2026 to approve the Audited Financial Results for the Quarter and the Financial year ended March 31, 2026.
Interim / Quarterly Report FY 2026
2026-05-12 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2026-04-23 English
Intimation of Newspaper Advertisement by Novartis India Limited (''the Company'')- Completion of e-mailing of Notice of Postal Ballot to the Members of the Company.
Proxy Solicitation & Information Statement
2026-04-17 English
Notice of Postal Ballot - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 ("Listing Regulations").
Proxy Solicitation & Information Statement
2026-04-16 English
Certificate in terms of Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018 for the Quarter and Financial Year ended March 31, 2026, issued to Novartis India Limited ....
Regulatory Filings
2026-04-13 English
Intimation of Newspaper Advertisement by Novartis India Limited ("the Company")- Information regarding Postal Ballot/ E-Voting.
Regulatory Filings
2026-04-13 English
Disclosure under regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover Regulations, 2011).
Regulatory Filings
2026-04-07 English
Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve The Audited Financial Results ....
Regulatory Filings
2026-03-31 English
Intimation of meeting of Board of Directors of Novartis India Limited("the Company") and Closure of Trading Window.
Board/Management Information
2026-03-31 English
Intimation of the receipt of Delhi High Court Order admitting Company Petition in the matter of Novartis India Limited vs. Commissioner of Trade and Taxes (W.P.(C) 3892/2026)
Legal Proceedings Report
2026-03-30 English
Intimation is hereby given that an order for demand was received on March 27, 2026, under Section 156 of the Income Tax Act, 1961. Further, an Order in the same regard has been received ....
Regulatory Filings
2026-03-27 English
This is to inform that Ms. Gowree Gokhale (DIN: 09351661) has been appointed as an Additional Director (designated as non-executive and Independent Director) w.e.f. April 01, 2026, for ....
Board/Management Information
2026-03-27 English
Outcome of the meeting of the Board of Directors of Novartis India Limited (''the Company'') held today i.e. Friday, March 27, 2026 to inter-alia approve the completion of second tenure ....
Board/Management Information
2026-03-27 English
Outcome of the meeting of the Board of Directors of Novartis India Limited (''the Company'') held today i.e. Friday, March 27, 2026 to inter-alia approve the appointment of Ms. Gowree Gokhale ....
Board/Management Information
2026-03-27 English
Outcome of the meeting of Board of Directors of Novartis India Limited (''the Company'') held today i.e. Friday, March 27, 2026 inter-alia to approve the appointment of Ms. Gowree Gokhale ....
Board/Management Information
2026-03-27 English
The Company would hereby like to intimate to the Stock Exchange that, the Company has received from manager to the open offer (Axis Capital Limited) the draft letter of offer dated March 05, 2026.
Capital/Financing Update
2026-03-06 English
Axis Capital Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer to the public shareholders of Novartis India Ltd ("Target Company").
Merger & Acquisition
2026-03-06 English
Axis Capital Ltd ("Manager to the Open Offer") has submitted to BSE a copy Detailed Public Statement in terms of Regulation 3(1) and Regulation 4 read with Regulation 13(4), Regulation ....
M&A Activity
2026-02-26 English
The Detailed Public Statement ("DPS") in relation to the open offer received by Novartis India Limited ("the Company") dated Thursday, February 26, 2026.
Merger & Acquisition
2026-02-26 English
Axis Capital Limited ("Manager to the Offer") has submitted to BSE a copy of Public Announcement for the attention of the Public Shareholders of Novartis India Ltd under Regulation 3(1) ....
Regulatory Filings
2026-02-20 English
Receipt of Public Announcement in relation to open offer from Axis Capital Limited (Manager to the Open Offer).
Capital/Financing Update
2026-02-19 English
Disclosure under Regulation 30 of SEBI LODR Regulations.
Capital/Financing Update
2026-02-19 English
This disclosure is filed pursuant to regulation 30 and 30A of SEBI LODR regulations read with clause 5A of Para A of Part A of Schedule III of the Listing Regulations.
M&A Activity
2026-02-19 English
Clarification regarding incorrect financial figures of Novartis India Limited for Q3 2025-26 reported in Free Press Journal article dated January 28, 2026. The article has now been taken down.
Regulatory Filings
2026-01-29 English
Intimation of newspaper advertisement by Novartis India Limited (''the Company'') regarding the publication of Unaudited Financial Results of the Company for the quarter ended December 31, 2025.
Regulatory Filings
2026-01-29 English
Integrated Filing (Financial) for the Quarter ended December 31, 2025.
Regulatory Filings
2026-01-28 English
Outcome of the Meeting of the Board of Directors of Novartis India Limited ("the Company") held on Wednesday, January 28, 2026.
Regulatory Filings
2026-01-28 English
Certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations , 2018 for the quarter ended December 31, 2025, issued to Novartis India Limited ("The Company") ....
Regulatory Filings
2026-01-13 English